FI3884988T3 - Intravesikaalisesti siedettävä implantoitava laite - Google Patents

Intravesikaalisesti siedettävä implantoitava laite

Info

Publication number
FI3884988T3
FI3884988T3 FIEP21157457.9T FI21157457T FI3884988T3 FI 3884988 T3 FI3884988 T3 FI 3884988T3 FI 21157457 T FI21157457 T FI 21157457T FI 3884988 T3 FI3884988 T3 FI 3884988T3
Authority
FI
Finland
Prior art keywords
drug
lumen
dimension
configuration
retention
Prior art date
Application number
FIEP21157457.9T
Other languages
English (en)
Finnish (fi)
Inventor
Michael Cima
Heejin Lee
Original Assignee
Taris Biomedical Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taris Biomedical Llc filed Critical Taris Biomedical Llc
Application granted granted Critical
Publication of FI3884988T3 publication Critical patent/FI3884988T3/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/18—Materials at least partially X-ray or laser opaque
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/042—Urinary bladders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/22—Materials or treatment for tissue regeneration for reconstruction of hollow organs, e.g. bladder, esophagus, urether, uterus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Optics & Photonics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Prostheses (AREA)
FIEP21157457.9T 2009-12-17 2010-12-17 Intravesikaalisesti siedettävä implantoitava laite FI3884988T3 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28764909P 2009-12-17 2009-12-17
US32571310P 2010-04-19 2010-04-19

Publications (1)

Publication Number Publication Date
FI3884988T3 true FI3884988T3 (fi) 2025-08-08

Family

ID=43769298

Family Applications (1)

Application Number Title Priority Date Filing Date
FIEP21157457.9T FI3884988T3 (fi) 2009-12-17 2010-12-17 Intravesikaalisesti siedettävä implantoitava laite

Country Status (18)

Country Link
US (4) US8679094B2 (enExample)
EP (2) EP2512581B1 (enExample)
JP (3) JP2013514837A (enExample)
AU (1) AU2010339821B2 (enExample)
CA (1) CA2784601C (enExample)
CY (1) CY1124354T1 (enExample)
DK (2) DK2512581T3 (enExample)
ES (2) ES3038403T3 (enExample)
FI (1) FI3884988T3 (enExample)
HR (2) HRP20210329T1 (enExample)
HU (1) HUE053888T2 (enExample)
LT (2) LT3884988T (enExample)
PL (2) PL3884988T3 (enExample)
PT (2) PT3884988T (enExample)
RS (2) RS67130B1 (enExample)
SI (2) SI3884988T1 (enExample)
SM (2) SMT202500293T1 (enExample)
WO (1) WO2011084712A1 (enExample)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8668705B2 (en) 2005-05-20 2014-03-11 Neotract, Inc. Latching anchor device
US10195014B2 (en) 2005-05-20 2019-02-05 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US7645286B2 (en) 2005-05-20 2010-01-12 Neotract, Inc. Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures
US10925587B2 (en) 2005-05-20 2021-02-23 Neotract, Inc. Anchor delivery system
US9549739B2 (en) 2005-05-20 2017-01-24 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US8603106B2 (en) 2005-05-20 2013-12-10 Neotract, Inc. Integrated handle assembly for anchor delivery system
US7758594B2 (en) 2005-05-20 2010-07-20 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US8628542B2 (en) 2005-05-20 2014-01-14 Neotract, Inc. Median lobe destruction apparatus and method
US9017312B2 (en) * 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
CA2784601C (en) * 2009-12-17 2016-06-14 Taris Biomedical, Inc. Implantable device with intravesical tolerability and methods of treatment
US20110218488A1 (en) * 2010-03-05 2011-09-08 Taris Biomedical, Inc. Systems and Methods for Implanting Devices in the Bladder and Other Genitourinary Sites
US20110308835A1 (en) * 2010-06-16 2011-12-22 Piekny Mark G Self-coiling apparatus
PT2600800T (pt) 2010-08-05 2020-11-05 Taris Biomedical Llc Dispositivo de administração de drogas por stent ureteral, kit e método
US9457176B2 (en) 2010-10-06 2016-10-04 Taris Biomedical Llc Implantable drug delivery device with bladder retention feature
JP5945544B2 (ja) 2010-10-06 2016-07-05 タリス バイオメディカル エルエルシー 時間選択的に生体吸収可能または崩壊可能な薬剤送達システムおよび方法
US8679093B2 (en) 2010-11-23 2014-03-25 Microchips, Inc. Multi-dose drug delivery device and method
RU2620032C2 (ru) * 2011-01-10 2017-05-22 Аллерган, Инк. Схема приема лидокаина для применения в продолжительном лечении боли в мочевом пузыре и раздражения при мочеиспускании
CA2825399A1 (en) 2011-02-04 2012-08-09 Taris Biomedical, Inc. Implantable device for controlled release of low solubility drug
US10292801B2 (en) 2012-03-29 2019-05-21 Neotract, Inc. System for delivering anchors for treating incontinence
US10610294B2 (en) 2012-04-22 2020-04-07 Newuro, B.V. Devices and methods for transurethral bladder partitioning
US9883906B2 (en) 2012-04-22 2018-02-06 Newuro, B.V. Bladder tissue modification for overactive bladder disorders
US9387163B2 (en) * 2012-04-30 2016-07-12 Allergan, Inc. Methods for treatment of pelvic pain and/or comorbid conditions
BR112014028916B1 (pt) * 2012-05-19 2022-01-11 Taris Biomedical Llc Dispositivo médico
US10130353B2 (en) 2012-06-29 2018-11-20 Neotract, Inc. Flexible system for delivering an anchor
PT2890384T (pt) 2012-08-31 2022-01-21 Taris Biomedical Llc Sistemas e métodos para administração de fármacos para tratamento de cancro de bexiga contendo oxaliplatina
WO2014036556A2 (en) 2012-08-31 2014-03-06 Taris Biomedical, Inc. Drug delivery systems and methods for treatment of prostate
AU2013318146B2 (en) * 2012-09-18 2018-05-10 Taris Biomedical Llc Drug delivery systems and methods for treatment of bladder voiding dysfunction|and other lower urinary tract disorders by using trospium
WO2014138214A1 (en) 2013-03-05 2014-09-12 Taris Biomedical, Inc. Drug delivery devices and methods for controlled drug release through device orifice
PT2968880T (pt) 2013-03-15 2025-07-07 Taris Biomedical Llc Dispositivos de aplicação de fármaco com componente permeável a fármaco
MX391755B (es) 2013-03-15 2025-03-21 Taris Biomedical Llc Dispositivos de administración de medicamentos y métodos para administración de medicamentos.
SMT202000472T1 (it) 2013-08-19 2020-11-10 Taris Biomedical Llc Dispositivi di somministrazione di farmaco multi-unità
RU2016120199A (ru) 2013-11-05 2017-12-11 ТАРИС Биомедикал ЛЛК Осмотические устройства, комплекты и способы для доставки лекарственных средств
SI4124339T1 (sl) * 2014-03-06 2025-11-28 Taris Biomedical Llc Sistemi za dostavo zdravila in metode za zdravljenje raka mehurja z gemcitabinom
JP2017519541A (ja) 2014-05-12 2017-07-20 タリス バイオメディカル エルエルシー 薬物送達装置及び方法
EP3160442B1 (en) * 2014-06-26 2019-03-06 TARIS Biomedical LLC Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems
US20170246437A1 (en) 2014-09-12 2017-08-31 Taris Biomedical Llc pH-MODULATING DRUG DELIVERY DEVICES AND METHODS
ES2734394T3 (es) 2015-03-30 2019-12-05 Taris Biomedical Llc Dispositivos para la administración local fármacos al tracto urinario superior
GB201505527D0 (en) 2015-03-31 2015-05-13 Jmedtech Pte Ltd Composition
JP7425534B2 (ja) 2015-04-23 2024-01-31 タリス バイオメディカル エルエルシー 薬物透過性構成要素を有する薬物送達デバイス及び方法
US20180199816A1 (en) * 2015-05-26 2018-07-19 Taris Biomedical Llc Urodynamic assessment sysrems and methods
US10159850B2 (en) * 2016-01-06 2018-12-25 Covidien Lp Brachytherapy clip and applicator
WO2017132372A1 (en) 2016-01-26 2017-08-03 Taris Biomedical Llc Multi-lumen drug delivery devices
WO2017151983A1 (en) 2016-03-02 2017-09-08 Taris Biomedical Llc Osmotic drug delivery devices and methods of making osmotic drug delivery devices
MX389296B (es) 2016-05-06 2025-03-20 Taris Biomedical Llc Metodo para tratar cancer urotelial del tracto inferior.
US11707611B2 (en) * 2016-11-08 2023-07-25 W. L. Gore & Associates, Inc. Implantable apparatus for retention of biological moieties
CA3046087A1 (en) 2016-12-09 2018-06-14 Zenflow, Inc. Systems, devices, and methods for the accurate deployment of an implant in the prostatic urethra
ES2873084T3 (es) 2017-02-01 2021-11-03 Taris Biomedical Llc Dispositivos para la administración de fármacos in vivo
SG10201913998YA (en) 2017-07-25 2020-03-30 Taris Biomedical Llc Methods of treating tumor metastasis
JP2020536955A (ja) 2017-10-06 2020-12-17 ファウンドリー セラピューティクス， インコーポレイテッド 治療剤の制御放出のための埋込み可能なデポー
KR102892737B1 (ko) 2017-11-08 2025-11-28 타리스 바이오메디컬 엘엘씨 젬시타빈을 사용한 방광암의 치료 및 유지 요법의 방법
EP4218632B1 (en) 2017-12-23 2024-10-30 Teleflex Life Sciences LLC Expandable tissue engagement apparatus
CN116650732A (zh) 2018-01-08 2023-08-29 铸造疗法股份有限公司 经由治疗剂的控制递送用于治疗腔内癌症的装置、系统和方法
CN112367980A (zh) 2018-05-12 2021-02-12 铸造疗法股份有限公司 用于控制释放治疗剂的可植入贮库
WO2020028554A1 (en) 2018-08-01 2020-02-06 Taris Biomedical Llc Methods of treating overactive bladder using trospium
WO2020047013A1 (en) 2018-08-28 2020-03-05 Foundry Therapeutics, Inc. Polymer implants
US12440301B2 (en) 2018-11-07 2025-10-14 Teleflex Life Sciences Llc System for delivery of a fiducial marker
TW202333720A (zh) 2021-10-12 2023-09-01 美商塔里斯生物醫學有限責任公司 用於膀胱內施用的厄達替尼調配物及系統
CA3243565A1 (en) 2021-12-21 2023-06-29 Taris Biomedical Llc URINARY PLACEMENT CATHETER FOR INTRAVESICAL DEVICES
CA3252554A1 (en) 2022-02-18 2023-08-24 Taris Biomedical Llc ERDAFITINIB FORMULATIONS AND OSMOTIC SYSTEMS FOR INTRAVESICAL ADMINISTRATION
KR20250021376A (ko) 2022-06-08 2025-02-12 브라이트 유로, 아이엔씨. 비뇨기과적 감지를 위한 시스템 및 방법
US12426818B2 (en) 2022-06-08 2025-09-30 Bright Uro, Inc. Packaging assembly and method of preparing sensing device for insertion into a body cavity to preserve sterility
EP4536100A1 (en) * 2022-06-10 2025-04-16 Balt Usa, Llc Implants and systems for vascular treatment
WO2024092159A1 (en) 2022-10-28 2024-05-02 Taris Biomedical Llc Methods of treating bladder cancer with gemcitabine
CN120731076A (zh) 2023-02-13 2025-09-30 塔里斯生物医药公司 膀胱内施用厄达替尼以用于治疗膀胱癌
CN120731077A (zh) 2023-02-17 2025-09-30 塔里斯生物医药公司 膀胱内施用厄达替尼以用于治疗膀胱癌
AU2024249710A1 (en) 2023-04-10 2025-11-20 Taris Biomedical Llc Gemcitabine for use in methods of treating high-risk non-muscle invasive bladder cancer unresponsive to bacillus calmette-guerin therapy
CN117017567B (zh) * 2023-08-12 2024-04-09 上海市第一人民医院 一种植入式膀胱收缩系统、工作方法及人造膀胱
WO2025059602A1 (en) 2023-09-14 2025-03-20 Taris Biomedical Llc Methods of treating bladder cancer using intravesical administration of erdafitinib
TW202532086A (zh) 2023-10-02 2025-08-16 美商塔里斯生物醫學有限責任公司 治療對卡介苗療法無反應之高風險非肌肉侵襲性膀胱癌之方法
GB202401392D0 (en) * 2024-02-02 2024-03-20 Imphatec Ltd Implant for delivery of a drug

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016251A (en) * 1972-08-17 1977-04-05 Alza Corporation Vaginal drug dispensing device
US3935860A (en) * 1974-08-21 1976-02-03 Alza Corporation Intrauterine device with restrictor for maintaining device in uterine cavity
US4968507A (en) 1984-06-20 1990-11-06 Merck & Co., Inc. Controlled porosity osmotic pump
US4871542A (en) * 1987-04-30 1989-10-03 Ferring Service Center, N.V. Method and apparatus useful for delivering medicinal compositions into the bladder and urinary tract
GB2206046B (en) * 1987-06-25 1991-04-03 Alza Corp Multi-unit delivery system
MX9205850A (es) * 1991-10-10 1993-06-01 Alza Corp Dispositivos de surtido osmotico de farmaco con materiales de pared hidrofobicos
ES2150427T3 (es) 1992-06-02 2000-12-01 Bard Inc C R Procedimiento y dispositivo de implante para el suministro de farmacos a largo plazo.
US5516522A (en) * 1994-03-14 1996-05-14 Board Of Supervisors Of Louisiana State University Biodegradable porous device for long-term drug delivery with constant rate release and method of making the same
US6171298B1 (en) * 1996-05-03 2001-01-09 Situs Corporation Intravesical infuser
WO1998043555A1 (en) * 1997-04-03 1998-10-08 Point Biomedical Corporation Intravesical drug delivery system
US6749617B1 (en) * 1997-11-04 2004-06-15 Scimed Life Systems, Inc. Catheter and implants for the delivery of therapeutic agents to tissues
CZ303404B6 (cs) 1998-02-23 2012-08-29 Massachusetts Institute Of Technology Kompozice degradovatelného polymeru s tvarovou pametí a predmet z nej vyrobený
US6183461B1 (en) * 1998-03-11 2001-02-06 Situs Corporation Method for delivering a medication
US6159143A (en) * 1998-06-17 2000-12-12 Scimed Life Systems, Inc. Method and device for delivery of therapeutic agents in conjunction with isotope seed placement
US6293923B1 (en) * 1999-03-15 2001-09-25 Innoventions, Inc. Intravesicular balloon
US7135311B1 (en) * 1999-05-05 2006-11-14 Institut Curie Means for detecting and treating pathologies linked to FGFR3
US6139535A (en) * 1999-05-27 2000-10-31 Situs Corporation Method and apparatus for placement and activation of a medical device within a body cavity
DE60027458T2 (de) 1999-12-10 2007-07-05 Massachusetts Institute Of Technology, Cambridge Mikrochip-arzneistoffverabreichungssysteme und herstellungsverfahren
US6988983B2 (en) * 2000-04-14 2006-01-24 Solace Therapeutics, Inc. Implantable self-inflating attenuation device
US6682473B1 (en) * 2000-04-14 2004-01-27 Solace Therapeutics, Inc. Devices and methods for attenuation of pressure waves in the body
US6749553B2 (en) * 2000-05-18 2004-06-15 Theragenics Corporation Radiation delivery devices and methods for their manufacture
US6398718B1 (en) * 2000-06-15 2002-06-04 Innoventions, Inc. Intravesicular device
WO2003020210A2 (en) * 2001-08-29 2003-03-13 Umd, Inc. Vaginal delivery of chemotherapeutic agents and inhibitors of membrane efflux systems for cancer therapy
AU2002341959A1 (en) * 2001-10-04 2003-04-14 Case Western Reserve University Drug delivery devices and methods
US8685427B2 (en) 2002-07-31 2014-04-01 Boston Scientific Scimed, Inc. Controlled drug delivery
GB2385273B (en) * 2002-02-13 2004-05-26 Deborah Huang Drug delivery device
US6949125B2 (en) 2002-04-16 2005-09-27 Boston Scientific Scimed, Inc. Ureteral stent with end-effector and related methods
GB0211286D0 (en) 2002-05-16 2002-06-26 Nokia Corp Routing data packets through a wireless network
DE10247689A1 (de) * 2002-10-12 2004-04-22 Martin Rahe Implantat in der Harnblase
CA2503193A1 (en) * 2002-10-22 2004-05-06 The Biomerix Corporation Method and system for intravesicular delivery of therapeutic agents
US9440302B2 (en) 2002-12-16 2016-09-13 The Regents Of The University Of Michigan Assembly and planar structure for use therein which is expandable into a 3-D structure such as a stent and device for making the planar structure
US20050228482A1 (en) * 2003-09-26 2005-10-13 William Herzog Stent covered by a layer having a layer opening
JP2007521914A (ja) 2004-02-11 2007-08-09 エシコン・インコーポレイテッド 超小型電子機械システムを用いた尿力学評価方法および評価システム
US7862552B2 (en) * 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
EP1933810B1 (en) 2005-08-11 2012-10-10 Massachusetts Institute of Technology Intravesical drug delivery device and method
US20070255222A1 (en) 2006-03-27 2007-11-01 Changqing Li Catheter assembly including internal bolster
CA2661191C (en) 2006-08-23 2014-12-02 Svip 2 Llc Devices and methods for altering eating behavior
US20100076261A1 (en) * 2006-09-28 2010-03-25 Medvision Inc. Examination device
US8128576B2 (en) 2006-12-07 2012-03-06 Ethicon, Inc. System and method for urodynamic evaluation utilizing micro electro-mechanical system technology
AU2008335077B2 (en) * 2007-12-11 2014-05-29 Massachusetts Institute Of Technology Implantable drug delivery device ant) methods for treatment of the bladder and other body vestcles or lumens
EP2257250A2 (en) * 2008-01-29 2010-12-08 Gilbert H. Kliman Drug delivery devices, kits and methods therefor
KR101689786B1 (ko) * 2008-08-09 2016-12-26 메사츄세츠 인스티튜트 어브 테크놀로지 남성 비뇨생식기 및 주위 조직을 치료하는 방법 및 체내이식형 약물 전달 장치
US20100048266A1 (en) 2008-08-19 2010-02-25 Samsung Electronics Co., Ltd. Antenna device
US8343516B2 (en) * 2009-06-26 2013-01-01 Taris Biomedical, Inc. Solid drug tablets for implantable drug delivery devices
US9017312B2 (en) * 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
CA2784601C (en) * 2009-12-17 2016-06-14 Taris Biomedical, Inc. Implantable device with intravesical tolerability and methods of treatment

Also Published As

Publication number Publication date
US11065426B2 (en) 2021-07-20
PL2512581T3 (pl) 2021-11-02
PL3884988T3 (pl) 2025-09-08
US8679094B2 (en) 2014-03-25
SI2512581T1 (sl) 2021-09-30
HUE053888T2 (hu) 2021-07-28
US20210252262A1 (en) 2021-08-19
DK2512581T3 (da) 2021-03-29
PT2512581T (pt) 2021-04-27
JP2017189688A (ja) 2017-10-19
US11890439B2 (en) 2024-02-06
AU2010339821A1 (en) 2012-07-05
JP2016022392A (ja) 2016-02-08
SI3884988T1 (sl) 2025-09-30
SMT202500293T1 (it) 2025-09-12
LT2512581T (lt) 2021-03-25
EP2512581B1 (en) 2021-02-17
AU2010339821B2 (en) 2015-02-19
DK3884988T3 (da) 2025-08-18
JP6247270B2 (ja) 2017-12-13
SMT202100236T1 (it) 2021-05-07
JP2013514837A (ja) 2013-05-02
RS67130B1 (sr) 2025-09-30
JP6854210B2 (ja) 2021-04-07
PT3884988T (pt) 2025-09-01
US20240198067A1 (en) 2024-06-20
US20110152839A1 (en) 2011-06-23
ES3038403T3 (en) 2025-10-13
EP2512581A1 (en) 2012-10-24
US20140221981A1 (en) 2014-08-07
CY1124354T1 (el) 2022-07-22
ES2867399T3 (es) 2021-10-20
HRP20250946T1 (hr) 2025-10-10
WO2011084712A1 (en) 2011-07-14
LT3884988T (lt) 2025-08-25
EP3884988A1 (en) 2021-09-29
CA2784601A1 (en) 2011-07-14
EP3884988B1 (en) 2025-06-18
RS61980B1 (sr) 2021-07-30
HRP20210329T1 (hr) 2021-06-25
CA2784601C (en) 2016-06-14

Similar Documents

Publication Publication Date Title
FI3884988T3 (fi) Intravesikaalisesti siedettävä implantoitava laite
JP2013514837A5 (enExample)
JP2016532505A5 (enExample)
MX2021007933A (es) Dispositivos de suministro de farmacos con un componente permeable al farmaco y metodos.
SG179051A1 (en) Implantable device for controlled drug delivery
JP2009504271A5 (enExample)
MX2012003551A (es) Tabletas transformables via oral.
EP2432425A4 (en) MEDICAL IMPLANT
WO2010057082A3 (en) Diagnostic capsules, delivery/retrieval systems, kits and methods
WO2008108987A3 (en) Medical device with a porous surface for delivery of a therapeutic agent
IL299897A (en) Devices and methods for administering multiple units of drug
PH12016501083A1 (en) Drug delivery system
JP2010179112A5 (enExample)
IL208407A0 (en) Expansible biocompatible coats comprising a biologically active substance
DE60325267D1 (de) Vorrichtung mit einem expandierbaren teil für die arzneimittelfreisetzung
ATE508759T1 (de) Stent mit taschen für ein therapeutisches mittel
WO2014210315A3 (en) Stents and methods of use thereof
WO2008076383A3 (en) Stent graft with releasable therapeutic agent
WO2012012761A3 (en) Retaining mechanisms for prosthetic valves
BRPI0917006A2 (pt) agente de liberação prolongada de droga, adsorvente, alimento, máscara tendo um adsorvente, e, folha de adsorção
WO2011141866A3 (en) Stent devices for support, controlled drug delivery and pain management after vaginal surgery
JP2013525072A5 (enExample)
ES2531252T3 (es) Copolímeros aleatorios de metacrilatos y acrilatos
WO2009042315A3 (en) A biocompatible polymer system for extended drug release
BR112012004967A2 (pt) forma de dosagem oral, compreendendo pelo menos um agente biologicamente ativo, substâncias auxiliares da formulação e partículas magnetizáveis